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ABSTRACT
The Rose of Insulin and Thyroid Hormones in
the Behavioral Effects of Estradiol in Rats

June, 1977
R. Thomas Gentry, B.A., B.S., Florida Atlantic

University, Ph.D., University of Massachusetts

Directed by: Dr. George N. Wade

In the first series of experiments (Section I) the

body weight and food intake-suppressing effects of
endogenous ovarian hormones and injected estradiol

benzoate (EB) were compared in streptozotocin-diabetic
and non-diabetic female rats.

The absence of an effect

of diabetes indicated that the effects of estradiol

are not dependent on a change in the rate of insulin

secretion.

Instead, EB-treatment altered the effect of

protamine zinc insulin on these same measures, consistent

with the hypothesis that estradiol affects body weight
and food intake via its effect on the physiological

sensitivity to insulin.
The experiments of Section II examined the effects
of insulin on EB plus progesterone (P)-induced sexual

receptivity and the neural uptake of
ovariectomized female rats.

H-estradrol

m

The omission of insulin treat-

iv

merit

in streptozotocin-diabetic animals for the first

24 hours of a 20-hour or

54-

hour EB conditioning period

significantly reduced sexual receptivity.

Twenty-four

hours of insulin withdrawal was also found to reduce the
cell nuclear concentration of tritium in the hypothalamus,

preoptic area and pituitary gland, two but not six hours
z

after an intravenous injection of

H-estradiol.

In Section III the effects of hyper- and hypothyroidism
on sexual receptivity were investigated.

Seventeen days

of thyroxine treatment was found to reduce the responsive-

ness of ovariectomized rats to exogenously administered

EB and P.

This result was discussed in connection with the

known effects of thyroid hormones on estradiol metabolism.
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INTRODUCTION
The purpose of this series of experiments was to

extend our understanding of how estradiol influences behavior.

Two general approaches were taken.

In one

(Section I) the aim was to determine if a known effect
of estradiol, the suppression of body weight and food

intake, is mediated by an effect on another hormone

(insulin).

In the other approach (Sections II and III)

the possibility was tested that non-steroid hormones

(insulin and thyroxine) influence the sensitivity of a

behavior to estradiol conditioning.

In these cases the

behavior of interest was female sexual receptivity.
Both behaviors examined in these experiments are

believed to be mediated by direct estradiol action on
the brain, and there is reliable evidence to suggest

that the mode of estradiol action is similar to that in

non-neural reproductive tissues.

There are hormone-

sensitive cells which react to the presence of the hormone
and which initiate the subsequent series of physiological

events leading to behavioral responses.

process

in.

Similar to the

peripheral estrogen target tissue there is an

estrophilic protein in the cytosol of diencephalic brain
tissue which probably is a receptor.

Once the estradiol-

receptor complex is formed, it is translocated to the cell
nucleus where it interacts with chromatin. (For review of

2

this process see Jensen and DeSombre, 1973; Zigmond,
1975).

With the use of tritium-labelled estradiol it is
possible to quantify the amount of exogenously administered estradiol which is concentrated by neural
tissue.

Thus the linkage between hormone and behavior

can be separated into two portions: the binding of

estradiol by brain tissues and the events subsequent
to neural uptake.
4-

Thin technique was used in Experiment

to determine the effect of insulin on the quantity of

H-estradiol uptake in homogenized neural tissue.

3

SECTION

I

THE ROLE OP INSULIN IN THE INFLUENCE OP
ESTRADIOL ON FOOD INTAKE AND BODY WEIGHT
Following the withdrawal of endogenous estradiol by
ovariectomy, female rats overeat and display an accelerated rate of weight gain.

After several weeks the hyper**

phagia subsides, and the rate of weight gain returns to

preoperative levels when body weight is about 20# above
that of gonadally intact animals (Gentry & Wade, 1976; Mook,

Kenney, Roberts, Nussbaum & Rodier, 1972; Tarttelin &
Gorski, 1973).

Estradiol benzoate (EB) treatment to ovar-

iectomized rats reverses this pattern; there is an initial

period of hypophagia and weight loss for several weeks,
followed by a return to pretreatment levels of food intake
and body weight gain (Mook et al.

,

1972, Tarttelin & Gorski,

1966; Wade, 1975).

These observations have led several investigators to

conclude that the effect of estradiol on eating is secondary to the hormone's effect on body weight "set point"
(Mook, et al.

,

1972; Wade, 1972, 1976).

The change in

food intake is viewed as a regulatory mechanism to bring
the animals actual weight in line with the altered "set

point" for body weight or adipose content.
In a recent review of the general physiology of

(

4

-

hunger, Friedman and Strieker (1976) have concluded that
the notion of "set point" or "lipostat" is unnecessary if

the disposition of available caloric sources is taken into

account.

A physiological condition, for example, which in-

duces abnormally high storage of nutrients into adipose
tissue simultaneously draws caloric sources away from

oxidative processes and thereby necessitates an increase
in food intake in order to maintain a constant supply of

nutrients for oxidation.

Thus a mechanism for the effect

of estradiol on eating previously described as a change in

body weight "set point" may be that estradiol alters the

disposition of nutrients which then affects hunger by changing the availability of caloric sources.
One of the possible links between estradiol and the

control of nutrient storage and metabolism is insulin.

Insulin facilitates the removal of carbohydrates, amino
acids and fats from the blood and is effective in both

stimulating lipogenesis and inhibiting lipolysis.

The in-

jection of long-acting insulin greatly increases food intake
and body weight (e.g., Mackay, Callaway & Barnes,

194-0;

Hoebel & Teitelbaum, 1966).
The influence of reproductive hormones on insulin

function is suggested by the manifestation of clinical
diabetes mellitus in susceptible women during pregnancy
(Williams & Porte,

1974- )

and by the induction of insulin

5

resistance following the administration of estrogenic contraceptive steroids (e.g., Pyorala, Pyorala & Lempinen, 1967
Beck, 1969 ).

;

Estrogens also have been found to alter plas-

ma levels of insulin (Bailey & Hatty, 1971 ) and the rate
of insulin secretion from pancreatic islets in vitro

(Costrini & Kalkhoff, 1971

;

Hager, Georg, Leitner & Beck,

1972 ).

Thus it is proposed that estradiol may affect food
intake and body weight by either altering the endogenous

secretion of insulin or by influencing the action of
insulin.

This hypothesis is particularly appealing in light

of the facts that: high affinity estrogen receptors have

been identified in the same general diencephalic brain area
that is known to influence insulin secretion (Pfaff & Keiner, 1973 ; Woods & Porte, 1974-); and intracranial estradiol

implants into this same region effectively suppress eating
and body weight in ovariectomized rats (Beatty, O'Briant

& Vilberg, 1974

Jankowiak & Stern, 1974

-

-

;

;

Wade & Zucker,

1970 ).
The purpose of Section I was to investigate the role
of insulin function in the known effects of estradiol on

body weight and food intake.
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Experiment 1
Effect of Estradiol in Diabetic Female Rats

Experiment

1

was designed to evaluate the possibility

that the effects of estradiol on weight and food intake are

mediated by altering the rate of insulin secretion.

If,

for example, estradiol lowers plasma insulin levels there

would be decreased lipogenesis and increased lipolysis.
This in turn would increase the internal availability
of nutrients which would reduce food intake until the

net adipose mobilization returned to normal.

It is not

clear, however, whether estradiol alone inhibits or facil-

itates release of insulin is rats.

Hager et al. (1972)

found that estradiol suppressed the in vitro release of insulin, while Costrini and Kalkhoff (1971) fund an increase

under similar conditions.
To determine the contribution of changes in insulin

secretion, the effects of estradiol withdrawal and replace-

ment was compared in two groups of animals.

One group of

animals was "normal" (i.e., capable of altering insulin

secretion in response to estradiol); the other group was
diabetic and had insulin levels artificially held constant.
It

was reasoned that if changes in insulin secretion were

necessary, manipulations of estradiol would have signifi-

cantly attenuated effects on eating and weight in the animals with constant insulin levels.

7

Method
General Method for Experiment 1.

A total of 46

female rats (CD Strain, purchased from Charles River

Breeding Laboratories, Wilmington, MA) were used in these
experiments.

Each animal was housed in an individual

cage in an air conditioned room with a 12:12 light :dark
cycle, and allowed ad libitum access to Purina Laboratory

Chow and tap water.

Food intake was measured (to the near-

est 0.1 g) daily near the middle of the light period, and

body weights were recorded (to the nearest 1.0 g) every
third day.
To maintain constant levels of insulin, one group of

animals was first made diabetic with an intraperitoneal injection of streptozotocin (Upjohn) in citrate buffer
(100 mg/kg body weight) and then given daily subcutaneous

injections of 2.4 units of U80 protamine zince insulin
(PZI, Lilly). (In previous, unpublished studies this dose
of PZI was found to maintain the weight gain of strepto-

zotocin-diabetic animals parallel to nondiabetic controls.)
The diabetic condition of streptozotocin-injected animals

was confirmed by testing for glycosuria with TesTape
(Lilly).

Since diabetes can induce acyclicity in

female rats (Lawrence & Contopoulos, I960) it was also

necessary to confirm that the replacement doses of PZI

maintained normal cyclicity before the ovariectomies were

8

performed.

To do this vaginal smears were taken both

before and after streptozotocin treatment.
A second group of animals was not administered

streptozotocin and served as a "normal" control group
for all experiments.

Method for Part 1.

Effect of ovariectomy .

Twelve

days after the administration of streptozotocin approximately two-thirds of the animals in each group ("diabetic"

and "normal") were bilaterally ovariectomized while the

remaining one-third received sham operations (laparotomies).
Ovariectomies were performed through a single midventral
incision while the animals were under methoxyflurane (Metofane) anesthesia.

The food intake and body weight of the

resulting four groups (diabetic-ovariectomized; diabeticsham; normal-ovariectomized; and normal-sham) were recorded

for 36 postoperative days.
Method for Part 2.

Effect of estradiol benzoate .

The effect of estradiol benzoate (EB) on food intake and

body weight was evaluated in the ovariectomized animals
from Part 1.

Thirty-six days after surgery the ovariec-

tomized animals of each group were distributed into two
groups (N

=

6 or 7) approximately matched for body weight

and mean daily food intake.

Two of these matched groups

(one diabetic and one normal) were then biven daily in-

jections of 5 pg EB dissolved in 0.05 cc sesame oil, while

9

the other groups were biven daily injections of the
sesame oil vehicle alone.

Thus there were four groups

of ovariectomized animals in this part of Experiment 1:

diabetic-EB; diabetic-Oil; normal-EB; and normal-Oil.
All injections were biven subcutaneously in the back of
the neck and were administered near the middle of the

12-hour light period each day.

Food intake and body

weight were recorded for these animals for 15 days after
the initiation of EB injections.

Results of Experiment

1

Streptozotocin treatment .

The administration of

streptozotocin to 25 animals resulted in the death of 2
animals and confirmed diabetes mellitus, as indicated
by positive glycosuria (TesTape), in the remaining 25 animals.

Of these 25 animals and the 21 animals not given

streptozotocin 5 animals in each group were eliminated
from the subsequent experiments because they either died
or showed excessive food spillage; resulting in groups
of N = 20 and N = 18 for the diabetic and the non-

diabetic groups respectively.
Streptozotocin administrati on was followed by
a drop in both food intake and body weight three days

after treatment (Figure 1).

With daily injections

of 2.4 units PZI there was a rapid recovery of body

weight gain which was parallel to, but 5»0# below, non-

10

diabetic controls (Figure 1-A).

At 12 days after strepto-

zotocin treatment the mean daily food intake of diabetic
animals was 15$ above non-diabetic controls.

This

increased ad libitum eating was probably indicative of a

continued moderate state of diabetes despite PZI injections
sufficient to maintain normal weight gain.

Estrous cyclicity was maintained in all of the
animals given streptozotocin.

Mean cycle length was

4.33 + 0.12 (SEM) days before treatment and 4.55 +
0.23 days after treatment.

Results of Fart 1.

Effects of ovariectomy .

Bilat-

eral ovariectomy was performed in 14 streptozotocin-

treated animals and 12 non-diabetic animals and sham
operations were performed in the remaining 6 animals of
each group providing intact control animals.

After an initial drop in weight three days after
surgery both diabetic and non-diabetic ovariectomized
animals showed increased rates of weight gain compared to
the sham-operated controls (Figure 2A).

At the end of the

36-day observation period both ovariectomized groups
were about 17% heavier than their respective control
groups, t (18)
t (16) = 3.666,

=

3.828, £ < .01, for diabetics, and

£ <

.01, for non-diabetics.

A comparison of the increase in body weight of the
two ovariectomized groups relative to their controls (i.e.,

11

weight of ovariectomized group minus the weight of
sham-operated group) is shown in Figure 2-B.

The diabetic

animals showed an increase in weight after ovariectomy

very similar to normal, nondiabetic animals, and at 36
days after surgery both groups were exactly 49.8 g

heavier than their respective controls (Table 1).
The effects of ovariectomy on food intake are shown
in Figure 3-A.

After a 15-day delay both diabetic and non-

diabetic animals demonstrated a period of hyperphagia.
The relative increase in food intake in diabetic animals

was generally similar to that of normal animals (Figure
3-B).

A two-way analysis of variance of food intake over

the last 21 days of the observation period indicated that

there was no significant Treatment X Groups interaction,
F (1, 34) = 2.01?,

2 > 0 . 10 .

Results of Part 2.

treatment .

Effect of estradiol benzoate

Treatment with 5

jug

EB per day significantly

suppressed body weight in both diabetic and non-diabetic
animals, paired t (6)
=

5.088, £

<

=

2.976, £

<

0.05, and paired t (5)

0.01, respectively, while oil-injected cmtrols

continued to gain weight (Figure 4-A).

A comparison of

either the relative body weight curve (Figure 4-B) or
the final body weight (two-way analysis of variance) indi-

cated that the suppression of weight following EB treatment

was equivalent in diabetic and normal animals (Treatment X

12

Groups interaction: F (1, 22)

0.018, £ >0.50).

=

In nondiabetic animals EB treatment induced a

suppression in food intake which was maximum at 6 days after
the initiation of treatment (Figure 5-A).

The diabetic

animals showed a significant initial suppression of food
intake, t (6) = 2.714, £

<

.05, which was completely

reversed by Day 12 (Figure 5-B)

.

Fifteen days after

the beginning EB treatment the diabetic animals 'were eating
14 i 7# more than their controls.

was not quite significant, t (12)

Although this increase
=

2.022, 0.10

>

£

>

0 . 05 ;

the change in food intake from baseline to Day 15 was

significantly greater in diabetic animals than in normal
animals, t (11) = 5.046, £

Discussion of Experiment

<£.

0.02 (Figure 5-B).

1

In this experiment the effects of ovariectomy and

replacement estrogen therapy on voluntary food intake and
body weight were determined in animals which were diabetic
and given constant daily injections of a long-acting insulin

and the results were compared to those of normal, non-

diabetic animals.

In Part 1 it was found that ovariectomy

increased body weight and produced overeating in animals

with controlled levels of insulin in a manner very similar
to normal animals.

In Part 2 it was found that EB- treatment

to diabetic ovariectomized animals was followed by a supp-

13

ression in body weight very similar to that of normal
animals.

Food intake, however, was first suppressed then

increased by EB, unlike normal animals which showed some

undereating throughout the 15 -day observation period.
Taken together, the results of Parts

1

and 2 in-

dicate that the effects of estradiol on body weight are
not dependent on changes in insulin secretion since

animals which presumably could not alter insulin

secretion still showed normal body weight changes in
response to estradiol withdrawal or replacement.

In

general, food intake was also affected normally in

diabetic animals although the period of hypophagia following EB-treatment was shorter than in normal animals.
The normal suppression of body weight (Figure 4) and
a relative increase in food intake (Figure 5) seen after

15 days of EB administration may indicate either:

a) the

continued period of undereating is dependent on altered
(presumably lowered) plasma insulin levels; or b) estradiol induces a decrease in the effectiveness of insulin.
If the former is true it is difficult to explain why EB-

treatment would initially suppress eating.

Antagonism of

insulin by estradiol is tentatively supported by the

combination of lowered body weight and relative hyperphagia

which is qualitatively similar to the effects of streptozotocin (Figure 1).

,

Experiment 2
Effect of Estradiol On Insulin-Induced

Hyperphagia and Weight Gain
Although estrogens may not affect the secretion of
insulin it is possible that they modify the actions of
insulin.

This possibility is consistent with the results

of Experiment 1, Part 2 which showed that food intake

of diabetic animals given constant amount of insulin

increased above normal animals after 15 days of EB
treatment.

The reason that normal animals did not show

this secondary hyperphagia after EB administration may
be that they can compensate for the insulin-antagonism by

increasing their insulin secretion.
The hypothesis tested in Experiment 2 was that estra-

diol interacts to attenuate the effects of insulin relevant
to changes in body weight and food intake.

To test

this possibility, the known stimulatory effects of long-

acting insulin on weight gain and food intake (e.g.
Mackay, et al.

.

194-0;

Hoebel & Teitelbaum, 1966) were

compared in ovariectomized rats receiving either EB or
oil injections (Part 1).

Also of interest in this experiment was what happens
to food intake after the cessation of PZI injections.

Hoe-

bel and Teitelbaum (1966) found that obese rats with ventral medial hypothalamic lesions "regulated" their food

15

intake after a forced-feeding-induced further gain in
weight.

That is, when the animals were returned to

ad libitum feeding they reduced their intake until they

returned to their previous weight.

treatment in Part

1

Since the PZI-

increased the weight of ovariectomized

rats the analogous experiment for ovariectomy obesity is

reported

here (Part 2).

Method
General method for Experiment 2.

The 22 adult female

rats used in this experiment were born in the laboratory

and were derived (one generation) from CD-strain rats
(Charles River).

Methods of housing, feeding and watering

these animals were the same as in Experiment 1.

Pood

intake was recorded daily and body weights every fifth day.

Forty days before the initiation of PZI injections
all animals received bilateral ovariectomies as described

in Experiment 1.

On the day of surgery the animals were

divided into two groups matched for body weight.

Beginning

the day after ovariectomy and continuing through the

entire experiment one group (N

=

11) was given daily

injections of 5 pg EB while the other group (N

= 11)

received 0.05 cc of the sesame oil vehicle per day.
Method for Part 1.

injections .

Effects of protamine zinc insulin

Daily food intake was measured from three

days before the beginning of insulin injections through

16

the end of the experiment.

After the three-day baseline

period, all animals received daily, subcutaneous infections
of 2.4 units of protamine zinc insulin (PZI, Lilly).

On

the sixth day the dose of PZI was increased to 4.8 units

per day and this was continued for ten days.
Method for Part 2.

cessation .

Effects of protamine zinc insulin

The daily PZI infections were terminated while

the EB and oil infections were continued for ten more

days.

The recording of daily food intake and the measure-

ment of body weight every fifth day were continued during
this period.

Results of Experiment 2

After the initiation of PZI infections two animals
that had been in the group receiving EB died.

The data

of these animals was eliminated from all analyses leaving

N's of 9 and 11 for the EB and oil-infected groups

respectively.

Forty days after ovariectomy the mean weight of the

EB-treated group was 307*6 + 10.2 grams, and the weight
of the oil-treated animals was 15# higher (353.4- + 10.4

grams), t (18)

=

2.890, £

4.

0.01.

The mean food intake

of the two groups was closely matched (Table 2) indicating

that the period of hyperphagia had subsided, t (18)

p

>

0.10.

=

0.085,
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Results of Part 1.
injections.

Effects of protamine zinc insulin

During the first five days of PZI-treatment

(2.4 units per day) the mean daily food intake of the oil-

treated animals was significantly greater than that of EBtreated animals, t (18) = 2.596, £-< 0.05 (Figure 6-B,
Table 2).

The relative increase in body weight (i.e.,

over baseline), however, did not differ between the two
groups, t (18)

=

0.362,

£>

0.10 (Figure 6-A).

Ten days after the initiation of the high dose of
PZI (4.8 units per day) the oil-injected group had gained

37# more weight, t (18)

=

2.196,

£^ 0

.

05 , and during this

period consumed significantly more food, t (18)

£

=

2.771,

0.02, than the EB- injected animals.

Results of Part 2.

cessation .

Effects of protamine zinc insulin

During the last ten days of the experiment

three animals became ill or died.

The following analyses,

therefore, were based on the remaining nine EB- treated,
and oil-treated animals.
The cessation of PZI injections was followed by a

significant drop in body weight of both the oil-injected
and the EB-injected animals, paired t (8)
and paired t (7) = 2.425,

£<

=

3.843, £*£0.01,

0.05, respectively.

The

means of the weights after 10 days without insulin injections were not significantly different from the weights at

18

the beginning of PZI infections, paired t (8)

£ >0.10, and paired

=

t (7)

£>

0.089,

=

1.165,

0.10 (Figure 7-A).

The magnitude of the weight decrease was not different in
the two groups, t

(

15 ) = 0.167*

£

>

0.10.

The food intake of both groups showed

a

dramatic

initial decrease which was 25-30$ below that of baseline
(i.e., the mean daily food intake before insulin infections)

during tha first five days, paired t (8)
and paired t (7) = 4.801,

£^0.01

=

6 . 051 ,

(Figure 7-B).

£^

0.01,

During

the second five-day period intake recovered to about 90$
of baseline but was still significantly below baseline,

paired t (8) = 4.660, £<C0.01, and paired t (7) = 2.511,

£<

0.05.

The drop in food intake and partial recovery

was very similar in both groups of animals (Figure 7-B),
and the mean intake was not significantly different during

either the first, t
t

(

15 ) = 1.447,

£

>

(

15 ) = 0.686, £

>

0.10, or the second,

0.10, five day period.

Discussion of Experiment 2
In this experiment the effects of a long-acting

insulin we re determined in ovariectomized animals which
were receiving either estradiol benzoate or oil infections.
In Part

1

it was found that the oil-infected animals,

which were 15 $ heavier at the onset of insulin infections,
increased their eating and weight gain more than the EB-

treated animals (Figure 6).

These results are consistent
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with the hypothesis that estradiol attenuates the effectiveness of insulin on the metabolic events which mediate
insulin's effects on weight gain and hyperphagia.
In Part 2 of this experiment it was found that after
the cessation of insulin injections ovariectomized animals

lost weight and decreased their food intake in a pattern

very similar to that of estradiol-injected animals.

These

findings indicate that the obesity induced by the withdrawal of endogenous estrogens does not impair the ability
of these animals to make compensatory adjustments in

food intake and body weight following an experimental

further increase in weight.
General Discussion of Section

I

In the introduction of Section I

it

was suggested that

estradiol may affect the food intake and body weight of
rats by interacting with insulin.

Two possible mechanisms

of interaction were hypothesized: a) estradiol suppresses

the secretion of endogenous insulin or $ estradiol

attenuates the action of insulin on peripheral tissues.

Regardless of the particular mechanism, the suppression
of insulin's action on its target tissues (particularly
on adipose tissue) could theoretically be reflected in

the well-known effects of estradiol on eating and body

weight.
The general effect of insulin is to facilitate the
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clearance of plasma-born nutrients from the circulation.
Glucose, amino acids and fats are all affected by stimu-

lating their uptake into a variety of different tissues

including liver, muscle and adipose tissue.

The effects

on adipose tissue is emphasized here because the gain in

weight after ovariectomy is thought to be primarily
the result of increased fat (Kennedy, 1969; Leshner &

Collier, 1973).

Insulin promotes the storage of fats into

adipose tissue by several actions including: a) activating

lipoprotein lipase, which aids in the removal of triglycerides from the circulation; b) making available abundant

glycerol phosphate (formed from glucose by glycolysis)

which esterifies with fatty acids to produce triglycerides;
and c) by inhibiting the hormone-sensitive lipase which

functions to mobilize triglycerides from adipocytes.
If estradiol interferes with these actions of in-

sulin on adipose tissue the result would be a temporary

increase in the rate of lipolysis relative to the rate of
lipogenesis.

This effect would be self-limiting because

as the adipocytes decreased in size lipolysis would tend

to decrease (Gold.rick & McLoughlin, 1970; Hartman, Cohen,

Richane & Hsu, 1971).

Thus there would be a temporary

change in body fat (and weight) which would then stabilize
at the point where the rates of lipolysis and lipogenesis

are once again approximately matched.
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During the period when adipose stores are diminishing
the nutrients which would normally be directed toward

adipose storage would instead accumulate at other sites.

Assuming this increase in available caloric sources would
be reflected in the physiological processes relevant to
the control of hunger (e.g., hepatic oxidative metabolism,

Friedman & Strieker, 1976), voluntary food intake would
be expected to: first decrease during the period of

decreasing adipose stores (i.e., during weight loss);
then return to normal when the balance between lipolysis
and lipogenesis is reestablished (i.e., when the rate of

weight gain returns to normal).
Thus the observations of transient changes in food

intake and the rate of weight gain and the permanent
changes in body weight and adipose content are consistent

with the proposition that estradiol interacts with insulin function.

Furthermore, emphasizing the effects of

estradiol on the systemic disposition of nutrients,

eliminates the necessity of using body weight "set point"
or lipostat to explain the same observations.

What remains to be established is the connection

between estradiol and insulin function.

The two possible

mechanisms of interaction discussed here are: a) estradiol

suppression of the endogenous secretion of insulin; b)
estradiol attenuation of the action of insulin.
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The effect of estradiol on insulin secretion

The incubation of rat pancreatic islets with estra-

diol for two hours does not affect subsequent insulin

responses to glucose stimulation (Costrini
1971).

8c

Kalkhoff,

The in vivo administration of estradiol for at

least two weeks before the isolation of islets, however,

does affect insulin secretion but the results are inconsistent.

Costrini and Kalkhoff (1971) found that 5

(but not 1.25 or 2.5

jug)

jug

estradiol benzoate per day for

three weeks significantly stimulated the In vitro insulin

Hager et al. (1972) on

release in response to glucose.
the other hand, found that 7.5

jug

of non-esterified

estradiol per day for approximately the same length of time
suppressed glucose stimulated insulin release measured
in vitro .

They concluded that the discrepancy may be a

function of a difference in the incubation times of the
islets in the presence of glucose (in the Hager et al,
study the incubation period was 10 minutes and for the

Costrini and Kalkhoff study it was 90 minutes) and
suggested that of the two distinct phases of insulin

release to constant glucose stimulation (Curry, Bennett
& Grodsky, 1968), pretreatment with estradLoL may suppress
the first and augment the second.

The effect of estradiol on plasma insulin levels in
rats tends to agree with the findings of Costrini and
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Kalkhoff (1971), since Bailey and Matty (1972) found
that the administration of EB to ovariectomized animals

increased the magnitude of insulin secretion in response
to an intraperitoneal glucose challenge.

Because the effects of insulin increase food intake
and body weight (e.g.

,

Hoebel & Teitelbaum, 1966), it

would be expected that if changes in circulating insulin
levels mediate the effects of estradiol, insulin secretion
should be decreased by estradiol.

Instead the evidence

just reviewed indicates that estradiol ultimately stimu-

lates the release of insulin.
In Experiment 1 the specific end-points of interest
(food intake and body weight) were examined in order to

determine if the experimental maintenance of constant
insulin levels could block the effects of estradiol.

The

results were that holding insulin levels constant had no
effect on either ovariectomy or EB replacement therapy,

which indicated that a change in insulin plasma levels
is not necessary for the expression of estradiol's action

on eating and weight.

This conclusion is independently

supported by noting previous reports which found that if

estradiol does affect insulin secretion, it does so in
the wrong direction to cause a decrease in body weight and

food intake.

The effect of estradiol on insulin action

Insulin resistance.

As mentioned in the introduction

some women are susceptible to diabetes during pregnancy.

In "gestational diabetes" there is decreased glucose tolerance despite significant increases in plasma immunoassayable

insulin, and even "normal" pregnant women show hyperinsulin-

emia in the presence of normal plasma glucose levels

following a glucose challenge (Kalhoff, Schalch, Walker,
Beck, Kipnis & Daughaday, 1964 ).

These effects are consid-

ered to be the result of peripheral resistance to insulin

action (Burt, 1956 ; Knopp, Ruder, Herrera & Freinkel,
1971)
1970) which induces a compensatory hyperinsulinemia to main-

tain normal carbohydrate tolerance (Costrini & Kalkhoff,
.

In a recent review Kalkhoff (1975) found that a
total of eleven investigations involving 227 women indi-

cated that the synthetic oral estrogens, Premarin,

diethylstilbesterol, ethinyl estradiol and mestranol, induced a deterioration in glucose tolerance in a large

proportion (33/0 of the subjects; whereas a different set
of eleven investigations using parenterally administered

estrogens (principally estradiol and estriol) indicated
substantial improvements in glucose tolerance.

Kalkhoff

(1975) concluded that the observed effects of estrogens
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on glucose tolerance may depend on the type of estrogen

(e.g., natural vs. synthetic) and/or the route of admin-

istration employed.

Further complicating the picture of insulin resistance
during treatment with estrogens is the possibility that
there is a biphasic time course of action.

Lewis, Foglia

and Rodriguez (1950) found that estrogen treatment to

diabetic rats at first exaggerated hyperglycemia and then

reduced it.

In normal women treated with ethinyl estra-

diol plus norethindrone , the biphasic effect appears to

operate in the opposite direction; there is a transient

improvement in glucose tolerance following short-term

administration (Clinch, Turnbull & Khosla, 1969) and

deteriorated glucose tolerance after long-term use (e.g.,
Spellacy, Buhi, Spellacy, Moses & Goldzieher, 1970;
Spellacy, Buhi, Birk & McCreary, 1971).

Effects of estrogens on lipid metabolism .

In humans

the most commonly used estrogen components of oral contra-

ceptives (e.g., mestranol and ethinyl estradiol) have been
shown to induce marked (50-100^) increase in circulating

triglycerides and very low density lipoproteins (e.g.,
Hazzard, Spinger, Bagdade & Bierman, 1969; Gustafson &
Svanborg, 1972).

Some authors have concluded that this

hyperlipidemia is primarily the result of increased
hepatic triglyceride production (e.g.. Beck, 1975) while

others have emphasized the decreased rate of lipid

clearance (e.g.

,

Haraosh & Hamosh, 1975)*

The clearance of lipids from the circulation by
a number of tissues, including adipose, mammary and

heart tissue, depends upon lipoprotein lipase which is
activated by insulin.

A number of studies using human

and rat sugjects have demonstrated that both natural and

synthetic estrogens suppress adipose lipoprotein lipase
(Fabian, Stork, Kobilova & Sponarova, 1967; Hazzard et
al,

.

1969 ; Hamosh & Hamosh, 1975 )*

It is, therefore,

probable that the hyperlipidemia is at least partially
caused by the inhibition of lipoprotein lipase.
Thus it is possible that the interaction between

insulin and estradiol demonstrated in Section

I is at

least partially mediated by their effects on lipoprotein

lipase and is related to the known, effects of estrogens
on lipid metabolism.

Regardless of the specific mode

of action the results of Experiment 2 suggest that the

effects of estradiol benzoate and insulin are not

merely additive but are interacting since the effects
of insulin on body weight and food intake were sig-

nificantly attenuated in the presence of the estrogen.
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SECTION

II

THE EFFECT OF INSULIN ON ESTRADIOL-STIMULATED SEXUAL

RECEPTIVITY AND NEURAL UPTAKE OF

5 H-ESTRADIOL

The nutritional state of animals is knovm to

affect neuroendocrine-ovarian function.

Inanition due

to severe starvation is associated with a secondary anov-

ulatory syndrome in both rats and humans

—

possibly an

adaptive mechanism to limit population growth during periods of famine.

Body weight or percentage of weight

as fat is also known to affect the onset of regular

estrous or menstrual cyclicity at puberty (e.g.

,

Frisch &

McArthur, 1974; Gentry, unpublished observations;

Kennedy, 1969).

Although the physiological mechanisms involved in
these effects are unknown they are perhaps analogous to

similar effects which accompany untreated diabetes
mellitus.

Alloxan-diabetic rats, for example, are

characterized by either complete cessation of estrous
cycles (Lawrence & Contopoulos, I960) or irregular and

prolonged cycles (Levi & Weinberg, 1949).

Phe effects of

both starvation and diabetes are readily reversible.

In

the case of diabetes mellitus the administration of insulin results in the resumption of normal estrous cyclicity

within four to five days (Lawrence & Contopoulos, I960);
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and in the case of starvation normal cyclicity is restored

upon refeeding and a gain in body weight (e.g.. Crisp &

Stonehill, 1971).

Diabetes may affect estradiol action in the brain
(and thus neuroendocrine-ovarian function) by altering the

rate of oxidative metabolism in hypothalamic and amygdalar

tissue (Schiaffini, Marin and Foglia, 1970).

Another, and

not mutually exclusive mechanism, is indicated by the
results of Denari & Rosner (1972).

These investigators

looked at the uptake of radioactivity in homogenized an-

terior hypothalamic, pituitary, uterine and vaginal tissue

dissected from ovariectomized rats one hour after the in
x

vivo injection of

H-estradiol.

They found a significant

reduction in uptake (expressed as disintegrations per
minute (DPM)/mg of wet tissue) in the hypothalamic and

pituitary tissues of alloxan-diabetic animals compared
with nondiabetic controls.

They also found that insulin

replacement to diabetic animals reversed this effect.
Experiment 3
The Effect of Insulin on

Estradiol Stimulated Sexual Receptivity
Because the behavioral effects of estradiol are probably mediated by diencephalic uptake of the hormone (see

introduction) it is likely that the suppressed neur-

—
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al concentration in diabetics would be reflected in a

reduced behavioral sensitivity.

The purpose of the

following experiments was to determine if there is a
behavioral hyposensitivity to estradiol in diabetic
animals and also to confirm the findings of Denari and

Rosner

(

1972 ).

Method
General Method for Experiment 3.

All animals

(female rats of the CD strain purchased from Charles

River Breeding Laboratories) were first ovariectomized and
then made diabetic with an intraperitoneal injection of

streptozotocin (100 jug/kg body weight).
given daily injections of

3

Each animal was

units Lente insulin (Lilly)

a dose which maintained steady body weight.

Comparisons

between "diabetics" and "nondiabetics" were actually com-

parisons between animals that had their insulin injections
omitted for one or two days and animals that had uninter-

upted daily injections of insulin.

In the behavioral

experiments this procedure allox^ed the comparison of the
same animal under both "diabetic" and "nondiabetic" condi-

tions.
All animals were housed in individual cages under a

12:12 light: dark cycle and were given ad libitum access
to Purina Laboratory Chow and tap water.

«
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Sexual receptivity was determined by scoring the

quality of the lordosis to each mount by a male rat as
0, 1, 2 or 3, where 0 refers to no lordosis and 3

represents a maximal response (Powers & Valenstein, 1972).
The mean score in response to ten mounts represented the

animal's "mean lordosis rating" (MLR).

Behavioral test-

ing was done under dim red light illumination in a circular
"arena" approximately six hours after the beginning of

darkness.

Testing sessions were separated by a minimum

of six days and a maximum of eight days.

For all behavior paradigms

1

mg progesterone was

injected subcutaneously six hours before testing and

wither 2 or 4

/ig

EB/kg body weight was injected either

54 or 30 hours before testing.

The body weight used to

calculate the EB dosage was the last weight recorded before
the omission of an insulin injection.

At the time of the

EB injection all animals in the "diabetic" condition were
checked for glycosuria with TesTape.

The data for any

animals which were not glycosuric were not used in the

statistical analysis.
Method for Part
c ondit i oning

1.

Fifty-four hour estradiol benzoate

All animals were tested under both of the

following conditions.

In the "diabetic" condition, the

insulin injection which was normally given near lightsout 54 hours before behavioral testing was omitted and
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either 2 or 4

EB/kg body weight was administered at this

jjg

The insulin injections on the day of testing and

time.

the day between EB injection and testing were given as per

normal schedule.
given

54-

In the "nondiabetic" condition, EB was

hours before testing and the insulin injection

was not omitted on that day.

The behavioral testing was

done "blind", and the order of conditions was counter-

balanced so that on any one testing day, half of the animals were in each condition.

Method for Part 2.
conditioning.

Thirty-hour estradiol benzoate

Again each animal was tested under both

a "diabetic" and a "nondiabetic" condition in counterbalance

order.

This time the delay between EB injection and

testing was 30 hours and in the "diabetic" condition the
insulin injection was omitted on the day before be-

havioral testing.

Because the MLR was found to be too

low to show any suppression with 2 ^g EB/kg, only the

4-

jig/

kg dose was used in Part 2.
Method for Part 3.

Control.

It is unlikely that

animals in the "diabetic" condition were sick during the
time of testing because they had received one or two insulin

injections after the day of insulin omission.

But to test

for the possibility that a general malaise could explain

suppressed sexual receptivity in the "diabetic" condition
some animals were tested on the same day that the insulin
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injection is omitted.

In this case EB injections were

given 50 hours before behavioral testing and the insulin

injection scheduled for 6 hours before testing was omitted.

Again the same animals were tested in this "diabetic" condition and in a "nondiabetic" condition in which there was
no insulin injection omission.

The nonparametric Sign Test

was used to evaluate changes in MLR and considered sig-

p<

nificant if

0.05, two-tailed (Siegel, 1956).

Results of Experiment 3
Results of Part

1.

Fifty-four hour estradiol ben-

zoate conditioning.

The results of Part 1 are shown at

the top of Figure 8.

With the low dose of EB (2 pg/kg)

the mean lordosis rating for the nondiabetic condition

was 0.49 + 0.24

(SET")

and the MLR for the diabetic con-

dition was not significantly different at 0.44 + 0.22,
Sign Test (N

= 6,

x

= 2),

£

>

0.30.

With the high dose of EB (4 pg/kg), however, there

was a greater than 25$ decrease in MLR when animals were
in the diabetic condition. Sign Test (N = 11, x = 2)

2

0.05.

The mean lordosis rating was 2.29 + 0.09 for

the nondiabetic condition, and 1.66 + 0.26 for the diabetic

condition.

Results of Part 2.
conditioning.

Thirty hour estradiol benzoate

The results of Part 2 are shown in the

middle of Figure 8.

The MLR for animals in the nondia-
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betic condition was 1.97 + 0 . 29 , and was 0.79 + 0.30 for

animals in the diabetic condition.

This difference was

statistically significant. Sign Test (N

£

<

x = 2),

0 . 05 .

Results of Part 5«
3

= 14,

Control.

The results of Part

are shown on the bottom of Figure 8.

The MLR for animals

tested on the day of insulin injection omission (1.90 +
0 . 51 ) was not significantly different from the test

conducted after no insulin injection omissions
0.24), Sign Test (N = 11, x = 6), £

>

0.50.

(

2.05 +

All of the

animals used in this analysis were glycosuric just before

behavioral testing in the diabetic condition.

Discussion of Experiment 3
The results of Part 1 indicated that the omission of
a single daily dose of Lente insulin on the day of EB in-

jection significantly suppressed sexual receptivity if the

EB dose was sufficient to avoid a "floor" effect.

The

reason animals in the diabetic condition showed no suppression when given 2

/jg

EB/kg was probably that the MLR even

in the nondiabetic condition was so low (0.49) that there

was little room for a further decrease.

More than half

of the animals tested with the low dose of EB showed MLR's

of 0.0 under both conditions and of the six animals which

did show some receptivity, four showed a suppression in
the diabetic condition.
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Because estradiol requires at least 17 hours to

condition receptivity (Green, Luttke & Whalen, 1970) and
continues to act to facilitate receptivity for more than
24-

hours it was thought that the insulin infection which

came

24-

hours after the EB injection may have reversed some

of the suppression of receptivity in the diabetic condition.

For this reason the 30-hour EB conditioning period was
tried in Part 2.
The results of Part 2 also indicated that the animals

conditioned with EB in the absence of insulin were less
receptive than when conditioned in the nondiabetic
state.

Analysis of the combined data of Parts

1

and 2

revealed a highly significant effect of insulin withdrawal,
Sign Test (N

=

25, x =

4-)

,

p

<

0.0005.

Although the effect

appeared greater in the 30-hour paradigm (Figure 8) this
observation could not be statistically confirmed or
rejected because the MLR is an ordinal rather than an
interval scale.
The results of the control experiment (Part 3) suggest

that the suppression of receptivity observed in Parts
and 2 was not the result of illness, since even when

tested while glycosuric, these animals showed normal
levels of receptivity.

1
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Experiment 4
Uptake of ^H-Estradiol
in Diabetic Ovariectomized Rats

The results of Experiment 3 indicated that the stim-

ulation of sexual receptivity by estradiol benzoate was

significantly attenuated if there was an absence of insulin during the first

24-

hours of the conditioning period.

Denari and Rosner (1972) had found that alloxan-diabetic, ovariectomized rats showed a decrease in uptake of

^H-estradiol into NaOH-digested hypothalamic and anterior

pituitary tissue.

They also showed that the uptake into

other tissues (vagina, uterus and diaphragm) was not sig-

nificantly affected by diabetes.

Because they did not

examine cell nuclear uptake, there was no information

available on whether there is an affect of diabetes on the

translocation of estradiol into the nuclei of target tissues.

The purpose of Experiment 4 was to reexamine the up-

take in the whole homogenate of neural and hypophyseal

tissue and to determine if there was any deficit in cell

nuclear uptake.

In addition to pituitary and hypothalamus,

uptake was also measured in an area just anterior to hypo-

thalamus including the preoptic area (which also shows a
great deal of specific uptake, e.g., Pfaff & Keiner,
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1973) and in the cerebral cortex, which shows relatively

little specific uptake.

Method
A total of 27 CD strain female rats were purchased

from Charles River Breeding Laboratories and used in this

experiment.

Each animal was ovariectomized and made

diabetic with streptozotocin at least one week before use
(procedures were the same as in Experiment 1).

As in

Experiment 3 all animals were diabetic and the "diabetic"
and "nondiabetic" conditions were differentiated by the

omission of insulin injections before the in vivo injection
z

of

H-estradiol and sacrifice.
Uptake Procedure.

^H-estradiol (specific activity

91.3 Ci/mole; New England Nuclear, Boston, MA) was injected

intravenously in 25$ ethanol.

At two (Part l) or six

(Part 2) hours after injection each animal was anesthetized

with sodium pentobarbital and a blood sample collected by
cardiac puncture into a heparinized syringe.

Rats were

killed by perfusion with 0.9# saline and the brain removed
and disected to sample: cerebral cortex (approximately
150 mg wet weight); preoptic area (50 mg); and hypothalamus
(60 mg).

The remaining brain portions were discarded.

The whole pituitary gland was also taken.

Each tissue was separately homogenized in a glass

homogenizer with a Teflon pestle at 4°C according to the
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method of McEwen and Zigraond (1972).

^1 of "whole homogenate" was taken.

Prom this sample 200
The remainder of the

sample (approximately 1.8 ml) was used to isolate the
cell nuclear fraction.

After isolation of the "nuclear pellet" (McEwen &
Zigmond, 1972) radioactivity was extracted from the whole

homogenate and nuclear pellet fractions three times with
A ml of toluene scintillation cocktail (5.0 g 2,5-diphenyl-

exazole and 0.05 g 1,4— bis-(2-(5-phenyloxazolyl))-benzene

per liter of scintillation grade toluene).

Protein was

precipitated with ethanol and measured by the method of
Lowry, Rosebrough, Farr and Randall (1951).

Blood samples

were centrifuged and a 0.1 ml sample of plasma was taken
and added directly to scintillation vials containing 12 ml
of the scintillation cocktail.

Radioactivity was counted in a Packard Instruments
Company Tri-Carb liquid scintillation spectrometer at an

efficiency of approximately 50$.

Radioactivity levels were

expressed as disintegrations per minute (DPM)/rog protein

taking into account the correction for quenching in each
sample.

Uptake schedule.

Pairs of animals, one "diabetic",

one "nondiabetic" were injected with ^H-estradiol 20 min-

utes apart with 90 minutes between the first animals of

each pair.

Pour or six animals were sacrificed in one
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day, and the first 3 H-estradiol injection was given approx-

imately 2 to 4 hours after the onset of the dark cycle.
Insulin injection schedule.

For animals in the "non-

diabetic" condition all insulin injections were given

according to the normal schedule, i.e., at the beginning
of the dark cycle each day.

For animals in the "diabetic"

condition the insulin injections on both the day before
uptake and the one scheduled a few hours before the uptake

were omitted.

The omission of this second injection was

necessary to avoid reversing the diabetic state caused by
the preceding 24 hour lack of insulin.

This schedule also

approximated the procedure used by Denari and Rosner (19?2).
Part 1.

Forty

jaCi

3

H-estradiol was injected 2 hours

before sacrifice to determine the whole homogenate and

nuclear pellet uptake of estradiol.
Part 2.

One hundred

/iCi

3

^H-estradiol was injected

6 hours before sacrifice to determine estradiol uptake

after a longer in vivo exposure.
Results of Experiment 4
Results of Part

1.

A total of 17 animals were used

in this part of the experiment;

8 animals in the diabetic

condition and 9 animals in the nondiabetic condition.

One

pituitary sample from an animal in the diabetic condition
was lost and, therefore, could not be used in the analysis
of that tissue

The results of Part 1 are shown in Figure 9 .

Two

hours after the injection of ^H-estradiol the plasma
level of radioactivity (measured as DPM/ml) was

lower

4-8$

in the non-diabetic condition than in the diabetic con-

dition, t (15)

=

3.84-6,

£<

0.01 (top of Figure 16).

The DPM/pg protein varied greatly among the different

tissues;

note the scale indication to the left of each

pair of bars for each tissue.

In the whole homogenates

(WH) of each of the tissues there was no reliable affect
of diabetic condition.

In the nuclear pellet (NP),

however, there was a significant suppression of uptake in:
the hypothalamus (Hth), t (15)

preoptic area (POA), t (15)

pituitary (Pit), t (15)

=

=

=

2.396, 2 -<0.05; the

2.865, 2 <1 0.02; and in the

3.081, 2

^ 0.01.

The slight

suppression of uptake which was observed in the cortical
(Ctx) nuclear pellet was not significant, t (15)

2

>0.10

=

1.634-,

(Figure 9).

The bottom of Figure 9 illustrates the NP to WH

ratio.

This measure is derived from the same data used

to generate the WH and NP bar graphs just above it and
is indicative of the amount of estradiol which has been

translocated into the nuclei of each tissue relative to
the amount of estradiol in the whole homogenate.

measure is shown on the same scale for

each,

This

tissue, but

there is still a notable variance among the different
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The NP/WH ratio in the diabetic condition showed

tissues.

a significant decrease for each of the following tissues:

hypothalamus, t (15)
t (15) = 3.094,

£<0.002;
1.878, £

>

=

3.823,

£< 0.002;

£<.0.01; and pituitary,

preoptic area,
t (14) = 4.087,

and no reliable effect in the cortex, t (15)

=

0.05.

Results of Part 2.

In this part of the experiment

10 animals were used; 4 in the diabetic condition and 6

in the non-diabetic condition.

The results of Part 2 are

summarized in Figure 10.
When animals were sacrificed six hours after the

infection of

3

H-estradiol there was much less radioactivity

in all tissues than when sacrificed after two hours, de-

spite the use of 2.5 fold more

3

H-estradiol (compare the

scales used on Figures 9 and 10).

Under these conditions

there were no significant differences between the diabetic
and the non-diabetic conditions in either the whole homo-

genate or the nuclear pellet fractions of any of the tissues
examined.
The plasma radioactivity was essentially the same in
the two groups of animals and the maximum suppression of

NP/WH ratio (in pituitary tissue) was not statistically
significant, t (8)

=

1.912, £>*0.05.

Discussion of Experiment 4
In this experiment the effect of diabetic condition
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on the uptake of 3 H-estradiol was investigated in three

neural tissues and the pituitary gland.

The pattern of

results obtained indicates that the withdrawal of insulin

injections from streptozotocin-diabetic animals significantly suppresses the concentration of ^H-estradiol in
the nuclear pellet fraction of several tissues two hours

after injection but has no effect six hours after injectThe suppression of uptake was found, in the pituitary

ion.

gland, the hypothalamus and the preoptic area, but not in
the cerebral cortex.

Denari and Rosner (1972) reported that diabetes in-

hibited the uptake of

3

H-estradiol in NaOH-digested hypo-

thalamic and anterior pituitary tissue.

This tissue

preparation can be considered equivalent to the whole
homogenate in the present experiment.

Since no effect

of insulin withdrawal was observed on whole homogenate

uptake, the findings of Denari and Rosner (1972) were not

confirmed.

One possible reason for this discrepancy may

be that while Denari and Rosner (1972) measured uptake one

hour after the administration of labelled estradiol the
shortest delay used in the present experiment was two
hours.
The results in Part 1 showing suppressed nuclear up-

take of ^H-estradiol but no effect on whole homogenate
uptake as the result of diabetes (note also the NP/WH

43

ratios in Figure 9) is indicative of reduced receptor
translocation, rather than a decreased affinity of the

receptor for estradiol or a decreased number of receptors.
This latter point is further supported by a recent pilot
study (Wade, unpublished observations) which indicated
that there was no decrease in the concentration of

cytosol estrogen receptors in the hypothalamic tissue of
ovariectomized, diabetic animals.
The deficit in nuclear uptake of radioactivity at

two hours (Part 1) was not seen when the animals were

sacrificed sixhours after the administration of labelled

estradiol (Part 2).

This is interpreted to mean that

the effect of diabetes is to retard, but not to completely

block the rate of receptor-estradiol complex translocation
into the nucleus.
It is not known how the lack of insulin could slow

the rate of nuclear translocation.

One possibility is

that the lack of insulin depletes the energy stores of
the particular cells which concentrate estradiol, and

this lowered energy reserve adversely affects the rate
of nuclear translocation.

Another possibility is that the

effect is secondary to some other effect of acute insulin

withdrawal such as hyperglycemia or hyperlipidemia.
The unusually high radioactivity levels in the plasma
of diabetic animals (top of Figure l) cannot account for
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-

7

.

the decreased neural and hypophyseal uptake of

H-estradiol

(by, for example, "pulling" estradiol away from these

tissues); because there is no deficit in the whole homo-

genate uptake.

General discussion of Section II
In Experiment 3 it was found that diabetes significantly reduced the facilitation of sexual receptivity by estra-

diol benzoate and in Experiment 4 it was

ffiund

that dia-

betes ratarded the translocation of estradiol into the
cell nuclei of the hypothalamus, preoptic area and pit-

uitary.

It seems likely, but difficult to prove, that

the suppression in the behavioral effects of EB are a

result of the demonstrated retardation in nuclear uptake
of estradiol.

Although the conditioning period for the

stimulation of receptivity by estradiol requires at least
17 hours (Green et al.

,

1970) the first few hours are

probably critically improtant.

This is likely to be

particularly true when the dose of estradiol benzoate is

very close to threshold.
Other reasons for the behavioral deficit cannot be
ruled out, however.

Perhaps, for example, the lack of

insulin also reduces the ability of some neural cells to

produce a particular protein or neurotransmitter which is

necessary for the display of sexual receptivity.
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SECTION

III

THE EFFECT OF THYROID HORMONES ON

ESTRADIOL STIMULATED SEXUAL RECEPTIVITY
Thyroid hormone is known to interact with hypophysealgonadal function.

Hyperthyroidism induces prolonged di-

estrus and hypothyroidism induces prolonged estrus in
female rats (Van Horn, 1935 )*

Although there is some evi-

dence that thyroid hormones have a direct effect on

gonadotropin release (in ovariectomized rats, La Rochele
& Freeman, 1974 ) the weight of the available findings

suggests that the effect in intact females is the result
of either changes in estrogen metabolism which accompany

changes in thyroid hormones or the altered response
of ovarian tissue to gonadotropins.

In ovariectomized

rats thyroxine -treatment suppresses and thyroidectomy

facilitates LH and FSH release (La Rochele & Freeman,
1974 ), but in hyperthyroid women LH levels are higher

than normal after exogenous estrogen treatment (Akande
& Hockaday, 1972 , cited in La Rochele & Freeman, 1974 )
and in thyroidectomized or propylthiouracil (PTU)-

treated rats hemicastration-induced compensatory hypertrophy is suppressed (Florsheim, Rudko, Corcorran &
Bodfish, 1967 ; Saiduddin, 1972 ) suggesting LH levels are

lower than normal.

Thus in gonadally intact females hyper-

thyroidism appears to cause hyposensitivity to the neg-
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ative feedback effect of endogenous estrogens, while hypo-

thyroidism appears to cause hypersensitivity.
These effects can be explained by the findings that

there is decreased ovarian steroid catabolism in hypo-

thyroid rats (Rail, Robbins & Lewallen, 1964; Tait & Burstein, 1964).

Gallagher et al. (1966) have reported that

while estradiol and estrone are in equilibrium (favoring
estrone), estrone is competitively metabolized to either

estriol or the catechol estrogen 2-OH-estrone, which is

further metabolized to 2-methoxyestronej and the direction
in which estrone is metabolized is influenced by thyroid

hormones.

In hyperthyroid individuals there is an increase

in 2-hydroxy- and 2-methoxy-estrone, while in myxedema

(hypothyroidism) there is an increase in estriol.

Thus

given the fact that estriol is, and 2-hydroxy- and 2-methoxyestrone are not effective estrogens on most physiological

measures including sexual receptivity it is suggested
that the systemic availability of estrogenic metabolites
of estradiol can be reduced by thyroid function.

Consistent with this hypothesis Ruh, Ruh and Klitgaard
(1970) found that the uterine whole homogenate concentra-

tion of in vivo injected ^H-estradiol was significantly

increased by thyroidectomy when measured 6, 10 or 16 (but
not 1) hour after injection.

Seven days of thyroxine

treatment (100 pg/kg body weight/day) tended to suppress
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5
^H-estradiol
uptake at 6, 10 and 16 hours postinjection

but the effect was not statistically significant.

Cidlowski and Muldoon (1975) determined cytosol

estrophile concentrations by in vitro incubation with
3

H-estradiol using uterine, hypothalamic and anterior pitu-

itary tissues of thyroidectomized, thyroxine treated or
control female rats.

They found no changes in receptors

of hypothalamus, but they did find that thyroxine treatment

decreased and thyroidectomy increased cytosol receptors
in uterine tissue of gonadally-intact animals.

Thyroxine is the only nonsteroid hormone which is

known to have an intracellular receptor which is
translocated into the cell nucleus.

It is relevant

therefore that Cidlowski and Muldoon (1975) also reported
that thyroxine does not compete for the estrogen receptors.
Thus it can he concluded that the increase in estradiol

uptake in hypothyroid animals, and the tendency toward

decreased uptake in hyperthyroid animals reported by
Rub et al. (1970) is not the result of competitive binding.

Experiment

5

Effects of Thyroid Hormones on Sexual Behavior

Relative decrements of reproductive behavior and

fertility have been associated with both hypo- and hyper-

thyroidism in several species (see Young, 1961, for a
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review).

In noncastrated animals these effects can be

considered secondary to the known effects of thyroid
hormones on gonadotropin secretion.

The only published

study using ovariectomized animals was done with long-

term (30 days) thyroidectomized guinea pigs (Hoar, Gov &
Young, 1957).

After infections of EB and progesterone,

thyroidectomized animals showed a significant decrement
in sexual receptivity compared with controls.

These

animals also showed reduced sexual activity during the

period between thyroidectomy and ovariectomy, and it is

possible that the reduced sexual activity in response
to EB and progesterone was the result of either unequal

conditioning before ovariectomy or the generalized
depressed metabolic state of long-term thyroidectomized
animals.

Another estrogen-sensitive behavior in rats which
has been examined in relation to thyroid function is

wheel running activity.

Stern

(

1970

;

Stern & Murphy, 1972 )

found that EB infections to ovariectomized rats could stimulate wheel running in both hypo- and hyperthyroid animals.
A comparison of the two studies reveals that

1

pg EB/day

was at least as effective in hypothyroid animals as 15

pg EB/day in hyperthyroid animals suggesting the possibility
that the behavioral sensitivity to estradiol is increased
in the absence of thyroid hormones.
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In the present experiments sexual behavior was tested
in EB and progesterone-primed ovariectomized rats before

and after short-term administration of PTU or thyroxine

Short-term PTU and T^ administration was used to

(T^).

avoid dramatic differences in mean body weight between
groups.

Method
Thirty female rats (CD strain, purchased from Charles

River Breeding Laboratories) were ovariectomized by the
same procedure as described in Experiment 1.

One animal

died in surgery and the remaining 29 animals were used
in all parts of the experiment.

Animals were housed in

individual cages in an air conditioned room with a 12:12
light: dark cycle and were fed Purina Laboratory Chow ad

libitum

.

Sexual receptivity was determined, by the same method
as described for Experiment 3.

To bring the animals into

heat 2 or 4 pg EB/kg body weight was injected 54 hours
before testing and 0.5 mg progesterone was injected 6

hours before testing.

All steroid hormone injections were

given subcutaneously in the back of the neck.

Each

behavioral testing period was separated by one week.

Testing sessions began approximately two hours after
the beginning of the dark cycle.

Scoring was done

"blind" as to which treatment each animal had received.

.

•
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After ovariectomy and before beginning propylthiouracil and thyroxine treatments each animal was tested

with both doses of EB.

The results of this test served

as a baseline to compare the change in mean lordosis

rating for each testing procedure and as a "screening"
to insure that every animal displayed some measurable

receptivity.

The scores on the screening test were also

used to assign each animal to one of three groups matched

for mean MLR.
One group of animals (N = 10) was made hypothyroid

by giving them PTU (0.04$, dissolved in tap water at

pH 8.5) in their drinking water.
animals (N

=

A second group of

10) was made hyperthyroid by daily intraper-

itoneal injections of L-thyroxine (25
saline at pH 11.5).

pig,

dissolved in

The third group of animals (N = 9)

served as controls and received daily intraperitoneal injections of saline (at pH 11.5)

Body weight was measured each week just before EB
injections and water intake was recorded daily for all
animals receiving PTU and for six animals in the control

group

Method for Part

1.

One day after the initiation of

PTU and thyroxine half of the animals in each group were
given 2 pg EB/kg while the other half were given
EB.

All animals were tested

54-

4-

ng/kg

tours later (on Day 5 of
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treatment).

Seven days later this same procedure was

repeated with each animal receiving the same dose of EB.
Method for Fart 2.

Because no facilitation of

receptivity was observed in the results of Part 1, on
the third testing session (Day 17 of treatment) all animals

were tested with the high dose of EB

(4-

;ig/kg).

Besults of Experiment 5
The data for one animal in the thyroxine-treated,

high-EB dose group were eliminated from the analysis
because this animal always held a low, crouched posture

never allowing males the opportunity to make a good
mount.
The body weight gain of PTU- treated animals between

baseline and Day 10 of treatment was 6 g in contrast to
21 g for controls, t (17) = 5*624, 2

^

0.01.

The mean

daily water intake was also about 65$ that of controls.
The results of behavioral testing 3, 10 and 17 days

after beginning PTU and thyroxine are summarized in Figure
11.

All three groups showed a general decrease in recep-

tivity over the testing periods.

There was no effect of

either PTU or thyroxine treatment on either Day 3 or Day
10.

On Day 17 the decrease in the PTU-treated animals was

essentially the same as the decrease in controls, Fisher
Exact Probability, 2 * 0.40.

The suppression of receptivity

in thyroxine treated animals, however, was significantly
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more common than in control animals, Fisher Exact Probability, £

0 . 05 .

Discussion of Experiment

5

This experiment was intended to test the effect
of hyper- and hypothyroidism on estradiol-stimulated

sexual receptivity in female rats.

The attempted

induction of hypothyroidism clearly had no effect
on sexual receptivity.

Since thyroidectomy has been

found to affect sexualreceptivity in guinea pigs (Hoar
et al.

,

1957)

the most likely explanation for the

present results is simply that the animals were not

hypothyroid.

Although suppressed weight gain was

observed in these animals and is usually indicative
of hypothyroidism, it is possible that the decreased

weight gain observed in this case was secondary to the
decrease in water intake.
The suppression of sexual receptivity by thyroxine

treatment was significant after 17 days of treatment.
The reason for this effect remains unclear.

However,

one possibility is that the thyroxine alters the

metabolism of estradiol toward less estrogenic or

possibly antiestrogenic compounds, i.e., the catechol
estrogens (Gallagher et al.

.

1966).

The estradiol metabolite which is decreased in
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hyperthyroid states is estriol (Gallagher et al.

,

1966).

This hormone must be given in a dose four-fold that of

estradiol to produce equivalent sexual receptivity in
female rats when administered in daily injections
(Beyer, Morali and Vargas, 1971). Daily injections,

however, producing pulses of estriol, do not mimic the
slow continuous conversion of estradiol to estriol and
this may have led to an underestimation of the behavioral potency of estriol.

This possibility is suggested

by the recent results of Clark, Paszko and Peck (1977)
on the uterotrophic effects of estriol.

These investi-

gators have found that whereas estriol is a weak uterotrophic agent when administered in daily injections it
is equivalent to estradiol when administered via paraffin

pellets.
The behavioral effect of estriol administered slowly
is unknown and until a significant agonistic effect of

estriol (or antagonistic effect of catechol estrogens)
can be confirmed, the hypothesis that thyroxine decreases
the behavioral response to estradiol by an alteration
of its metabolism remains incompletely tested.
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